There is a need for preclinical animal models such as mice and rats that are used to predict drug effectiveness and toxicity in humans. Due to their genetic similarities to humans as well as their large supply and ease of manipulation, rats are widely used. For instance, by inactivating or silencing an existing gene and replacing it with an artificial piece of DNA, Knockout rats are formed, resulting in the loss of gene activity. This leads to improvements in the phenotypic features of the rat, such as appearance, behavior, and other biochemical characteristics that are similar to human being. The high growth in using rat models can be due to their use to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, and other.
MARKET DYNAMICS
Rat model market is driving due to factors such as advancements in gene editing tools set to augment the demand for rat models, advantages offered by rats over mice, continuous support in the form of investments and grants, increased demand for personalized humanized rat models due to growing consumption of personalized medicines. However, factors such as, regulations & laws formulated for ethical use of animals and availability of alternatives to animal models through advance technologies is expected to hamper the market growth.
MARKET SCOPE
The Rat model market analysis to 2028 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Rat model market with detailed market segmentation by model type, service, therapeutic area, technology and end user. The Rat model market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Rat model market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The Rat model market is segmented on the basis of model type, service, therapeutic area, technology and end user. Based on model type, the market is segmented as outbred rats, inbred rats, knockout or genetically modified rats, hybrid or congenic rats, conditioned or surgically modified rats, immunodeficient rats. Based on service, market is segmented as breeding, cryopreservation, quarantine, rederivation, model-in-licensing, genetic testing, other services. Based on therapeutic areas, market can be segmented as toxicology, oncology, immunology and inflammation, neurology, diabetes, other therapeutic areas. Based on technology, market can be segmented as CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, other technologies. Based on end users, market is segmented as pharmaceutical and biotechnology companies, academic and research institutes, contract research organizations (CROs).
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Rat model market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Rat model market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Rat model market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Rat model market in these regions.
MARKET PLAYERS
The report covers key developments in the Rat model market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Rat model market are anticipated to have lucrative growth opportunities in the future with the rising demand for Rat model in the global market. Below mentioned is the list of few companies engaged in the Rat model market.
The report also includes the profiles of key players in Rat model market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Charles River Laboratories International,
- Envigo
- Taconic Biosciences
- Horizon Discovery Group
- genOway
- Laboratory Corporation of America Holdings
- Transposagen Biopharmaceuticals
- Transviragen
- Janvier Labs
- Biomere
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.